Drug profile

Here's what the FDA CVM extract says about Fiber Supplement

Fiber Supplement carries 10 FDA reports, lower-volume in the CVM extract. Read on for species, reactions, and outcomes.

#2581 of 2,679
by report volume (all drugs)
10
adverse-event reports
10.0%
death-coded share
Dog
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Fiber Supplement ranks #2536 of 2679 by total reports (10). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#2536
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Signature read: 10 reports place Fiber Supplement in the lower third of FDA AER volume (#2581 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
1
Deaths Reported
10.0%
Death-coded share of reports

Active Ingredients

Fiber Supplement

Administration Routes

OralUnknown

Species Affected

Dog 6
Cat 4

Most Affected Breeds

Domestic Shorthair 3
Lhasa Apso 1
Shih Tzu 1
Mastiff 1
Deutsche Dogge, Great Dane 1
Cat (unknown) 1
Maltese 1
Dog (unknown) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 3
Emesis 2
Anorexia 2
Weakness 2
Drooling 2
Not himself/herself 2
Stumbling gait 2
Loose stool 2
Lethargy (see also Central nervous system depression in Neurological) 2
Constipation 1
Disorientation 1
Lack of coordination (see also 'Ear' - vestibular disorder) 1

Outcome Breakdown

Recovered/Normal
5 (50.0%)
Ongoing
2 (20.0%)
Outcome Unknown
2 (20.0%)
Died
1 (10.0%)

Fiber Supplement: lower report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

  • Before drawing conclusions from this number, read why death-coded share is not the same thing as a mortality rate. Understanding adverse events
  • The full drug directory has report counts for every product we track. All drugs

Correlation in adverse-event counts is not causation; consult a veterinarian before making a decision from this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Fiber Supplement (#2581 of 2,679 by report volume); death-coded 10.0%. PlainBreed drug row · report volume stamp 10 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →